Stratum corneum TARC level is a new indicator of lesional skin inflammation in atopic dermatitis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 65, Issue 9, 2010, Pages 1166-1172

  Morita, E ^a   Takahashi, H ^a   Niihara, H ^a   Dekio, I ^a   Sumikawa, Y ^a   Murakami, Y ^b   Matsunaka, H ^b  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b TOKIWA Pharmaceutical Co Ltd   (Japan)

Author keywords

atopic dermatitis; stratum corneum; tape stripping; thymus and activation regulated chemokine

Indexed keywords

IMMUNOGLOBULIN E; LACTATE DEHYDROGENASE; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; EOSINOPHIL COUNT; ERYTHEMA; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LICHENOID ERUPTION; MAJOR CLINICAL STUDY; MALE; PAPULE; PRIORITY JOURNAL; SKIN CRUSTING; SKIN EDEMA; SKIN INFLAMMATION; STRATUM CORNEUM; TH2 CELL; XEROSIS;

ADOLESCENT; ADULT; CHEMOKINE CCL17; DERMATITIS, ATOPIC; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SKIN; YOUNG ADULT;

EID: 77955338605     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2010.02361.x     Document Type: Article

References (19)

1. Nakatani T, Kaburagi Y, Shimada Y, Inaoki M, Takehara K, Mukaida N et al. CCR4 memory CD4+ T lymphocytes are increased in peripheral blood and lesional skin from patients with atopic dermatitis. J Allergy Clin Immunol 2001 107 : 353 358.
2. Tamaki K, Kakinuma T, Saeki H, Horikawa T, Kataoka Y, Fujisawa T et al. Serum levels of CCL17/TARC in various skin diseases. J Dermatol 2006 33 : 300 302.
3. Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001 107 : 535 541.
4. Fujisawa T, Fujisawa R, Kato Y, Nakayama T, Morita A, Katsumata H et al. Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis. J Allergy Clin Immunol 2002 110 : 139 146.
5. Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol 2001 10 : 11 18.
6. Morita E, Hiragun T, Mihara S, Kaneko S, Matsuo H, Zhang Y et al. Determination of thymus and activation-regulated chemokine (TARC)-contents in scales of atopic dermatitis. J Dermatol Sci 2004 34 : 237 240.
7. Furue M, Saeki H, Furukawa F, Hide M, Ohtsuki M, Katayama I et al. Guidelines for management of atopic dermatitis. J Dermatol 2009 36 : 563 577.
8. Stalder JF, Taïeb A. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993 186 : 23 31.
9. Berner B, Akça D, Jung T, Muller GA, Reuss-Borst MA. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. J Rheumatol 2000 27 : 1128 1135.
10. Terui T, Hirao T, Sato Y, Uesugi T, Honda M, Iguchi M et al. An increased ratio of interleukin-1 receptor antagonist to interleukin-1alpha in inflammatory skin diseases. Exp Dermatol 1998 7 : 327 334.
11. Perkins MA, Osterhues MA, Farage MA, Robinson MK. A noninvasive method to assess skin irritation and compromised skin conditions using simple tape adsorption of molecular markers of inflammation. Skin Res Technol 2001 7 : 227 237.
12. Yamaguchi J, Aihara M, Kobayashi Y, Kambara T, Ikezawa Z. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis. J Dermatol Sci 2009 53 : 48 54.
13. Vestergaard C, Bang K, Gesser B, Yoneyama H, Matsushima K, Larsen CG. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol 2000 115 : 640 646.
14. Vestergaard C, Yoneyama H, Murai M, Nakamura K, Tamaki K, Terashima Y et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 1999 104 : 1097 1105.
15. Komine M, Kakinuma T, Kagami S, Hanakawa Y, Hashimoto K, Tamaki K. Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin. J Invest Dermatol 2005 125 : 491 498.
16. Horikawa T, Nakayama T, Hikita I, Yamada H, Fujisawa R, Bito T et al. IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis. Int Immunol 2002 14 : 767 773.
17. Hashimoto S, Suzuki T, Dong HY, Nagai S, Yamazaki N, Matsushima K. Serial analysis of gene expression in human monocyte-derived dendritic cells. Blood 1999 94 : 845 852. (Pubitemid 29361814)
18. Tamaki K, Saeki H, Kadono T, Sato S, Hatta N, Hasegawa M et al. Serum TARC/CCL17 levels as a disease marker of atopic dermatitis. Jpn J Dermatol 2006 116 : 27 39.
19. Asano S, Ichikawa Y, Kumagai T, Kawashima M, Imokawa G. Microanalysis of an antimicrobial peptide, beta-defensin-2, in the stratum corneum from patients with atopic dermatitis. Br J Dermatol 2008 159 : 97 104.